BLYG8824A

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BLYG8824A, covering 2025-04-25 to 2025-04-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BLYG8824A in Participants With Locally Advanced or Metastatic Colorectal Cancer [Phase 1]